Kura Oncology, Inc. KURA
What this company does
Written from the business description in KURA ONCOLOGY, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 5 March 2026. Every sentence was checked against that document before publication.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity lost 95 cents this year.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.1 | 0.1 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Operating income $B | −0.3 | −0.2 | −0.2 | −0.1 | · | · | · | · | · | · | · | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · | · | · |
| EBITDA $B | −0.3 | −0.2 | −0.2 | −0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · |
| Net income $B | −0.3 | −0.2 | −0.2 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.1 | 0.1 | −0.1 | −0.1 | −0.1 | −0.1 | · | · | · | · | −0.0 | · | · | · | · | · | · | · | · |
| EPS, diluted $ | −3.18 | −2.02 | −2.08 | −2.03 | −1.97 | −1.69 | −1.51 | −1.72 | −1.52 | −1.47 | −2.28 | −0.01 | −0.01 | −0.01 | −0.01 | 0.00 | · | · | · |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −94.8 | −42.9 | −37.3 | −29.3 | −23.3 | −21.6 | −33.3 | −50.2 | −51.8 | −39.7 | −57.5 | · | · | · | · | · | · | −184.6 | −42.8 |
| Shares out B | 0.09 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | · | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 19 of 19 fiscal years. 16 checks could not be computed.